diazeniumdiolate and Respiratory-Tract-Infections

diazeniumdiolate has been researched along with Respiratory-Tract-Infections* in 1 studies

Other Studies

1 other study(ies) available for diazeniumdiolate and Respiratory-Tract-Infections

ArticleYear
Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against
    ACS infectious diseases, 2020, 06-12, Volume: 6, Issue:6

    The formation of biofilms provides a formidable defense for many bacteria against antibiotics and host immune responses. As a consequence, biofilms are thought to be the root cause of most chronic infections, including those occurring on medical indwelling devices, endocarditis, urinary tract infections, diabetic and burn wounds, and bone and joint infections. In cystic fibrosis (CF), chronic

    Topics: Adult; Animals; Anti-Bacterial Agents; Azo Compounds; Biofilms; Cephalosporins; Cystic Fibrosis; Humans; Mice; Pseudomonas aeruginosa; Respiratory Tract Infections

2020